Related by context. Frequent words. (Click for all words.) 65 Phase 1b 63 Phase 2a clinical 62 Phase 2b study 62 linaclotide 62 avanafil 62 APF# 61 Phase IIa clinical 61 HspE7 61 tolerability profile 61 Zenvia 61 LymphoStat B 61 ADX# 61 Phase IIa 61 clinically meaningful 61 Phase 2a 61 dose escalation 61 ALKS 60 Phase Ib 60 tolerability 60 pharmacokinetic profile 60 MGCD# [001] 60 investigational drug 60 certolizumab pegol 60 PRX # 60 ACTEMRA 60 INCB# [002] 60 Phase IIa trial 59 pivotal Phase III 59 ARRY 59 Phase 2b clinical 59 dasatinib 59 monotherapy 59 satraplatin 58 picoplatin 58 fidaxomicin 58 mg dose 58 bortezomib 58 exenatide 58 pharmacodynamic 58 FOLOTYN 58 Phase IIb 58 dosing regimens 58 CK # 58 Phase III clinical 58 Phase 2b 57 Locteron 57 Phase IIb trial 57 naproxcinod 57 Fampridine SR 57 AMITIZA 57 ofatumumab 57 IMGN# 57 AP# [003] 57 Marqibo 57 RG# [001] 57 laquinimod 57 investigational compound 57 Entereg 57 primary endpoint 57 placebo controlled 56 mipomersen 56 pharmacodynamics 56 Ranexa 56 HUMIRA 56 SEROQUEL 56 CUDC 56 pharmacokinetic 56 Dyloject 56 CIMZIA 56 perifosine 56 carfilzomib 56 RDEA# 56 infliximab 56 oral formulation 56 VELCADE 56 XIAFLEX 56 humanized monoclonal antibody 56 antitumor activity 56 pivotal Phase 56 safety tolerability 55 Vectibix 55 daclizumab 55 primary efficacy endpoint 55 PMX # 55 FTY# 55 etanercept 55 CYT# 55 Phase III 55 pioglitazone 55 ENBREL 55 denosumab 55 Riquent 55 Contrave 55 evaluable patients 55 Albuferon 55 Actemra 55 ITMN 55 Iluvien 55 gefitinib 55 secondary endpoints 55 SPRYCEL